Understanding Family History of Ovarian Cancer is crucial for risk assessment and preventative care. This information is essential for clinical documentation, medical coding, and healthcare decision-making. Learn about Ovarian Cancer Family History, Hereditary Ovarian Cancer Risk, and the importance of documenting a detailed family history for accurate diagnosis and personalized treatment strategies. This knowledge supports effective patient care and informs medical professionals about genetic predispositions related to ovarian cancer.
Also known as
Family history of malignant neoplasms
Personal/family history of cancer, increasing risk.
Genetic susceptibility to malignant neoplasm
Increased risk of cancer due to genetic predisposition.
Noninflammatory disorders of ovary, fallopian tube, and broad ligament
Covers various ovarian conditions, not primarily inflammatory.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the patient being treated for ovarian cancer?
Yes
Do NOT code family history. Code the active ovarian cancer diagnosis.
No
Is there a confirmed family history of ovarian cancer?
When to use each related code
| Description |
|---|
| Increased ovarian cancer risk due to family history. |
| Genetic mutations increasing ovarian cancer risk (e.g., BRCA1/2). |
| Personal history of ovarian cancer. |
Coding F-codes requires specific details. Lack of documentation clarity on maternal/paternal lineage or cancer type may lead to unspecified coding.
Confusing personal history of ovarian cancer (Z85.820) with family history (F81.81) can lead to inaccurate coding and risk adjustment.
Documenting family history based on patient-reported information without confirmatory records introduces risk of inaccurate coding and potential overcoding.
Q: How can I effectively assess and manage ovarian cancer risk in patients with a strong family history of the disease?
A: Assessing and managing ovarian cancer risk in patients with a strong family history requires a multi-faceted approach. Begin by taking a detailed family history, noting the number of affected relatives, their age at diagnosis, and the specific types of cancer present. Consider creating a pedigree to visualize this information. For patients with multiple affected family members, particularly those diagnosed at a young age, or a history of breast and ovarian cancers in the same individual or family, genetic counseling and testing for mutations in genes like BRCA1, BRCA2, and other Lynch syndrome and hereditary cancer genes are strongly recommended. Explore how genetic testing criteria and guidelines can inform your decision-making process. Beyond genetic testing, consider discussing risk-reducing strategies such as prophylactic salpingo-oophorectomy with eligible patients. It's crucial to tailor management based on individual risk factors and patient preferences. Consider implementing a shared decision-making model to discuss the benefits, risks, and alternatives associated with each management option.
Q: What are the current best practice guidelines for ovarian cancer screening in women with a family history of ovarian cancer or BRCA mutation?
A: Currently, there is no universally recommended screening test for ovarian cancer in women with a family history, even those with a BRCA mutation. While CA-125 and transvaginal ultrasound may be used, their sensitivity and specificity are limited, leading to a high risk of false positives and potential for unnecessary invasive procedures. Current guidelines generally do not recommend routine screening with these methods in asymptomatic women. However, for higher-risk individuals (like those with BRCA mutations), some experts recommend individualized screening approaches. It's essential to discuss the limitations of current screening modalities with patients and emphasize the importance of promptly investigating any new or concerning symptoms. Learn more about ongoing research efforts to develop more reliable and effective ovarian cancer screening tests.
Patient presents with a concern regarding family history of ovarian cancer, increasing her risk of developing the disease. She reports a maternal aunt diagnosed with ovarian cancer at age 52 and a maternal grandmother diagnosed with primary peritoneal cancer at age 60. No known genetic testing has been performed within the family. The patient denies any current signs or symptoms such as abdominal pain, bloating, pelvic pressure, or early satiety. Physical examination, including pelvic exam, is unremarkable. Assessment includes family history of ovarian cancer, increasing her risk for ovarian cancer and possibly other hereditary cancer syndromes such as breast and ovarian cancer syndrome or Lynch syndrome. Plan includes detailed discussion of risk factors, genetic counseling referral for consideration of germline genetic testing such as BRCA1, BRCA2, and other relevant genes, and discussion of risk-reducing strategies including increased surveillance and prophylactic oophorectomy. Patient education provided on signs and symptoms of ovarian cancer, importance of follow-up, and available resources. ICD-10 code Z80.41 (family history of malignant neoplasm of ovary) documented. CPT code 99214 (level 4 established patient office visit) billed for this encounter, reflecting the complexity of medical decision-making regarding genetic counseling referral and discussion of risk reduction strategies. Patient agrees with the plan and will schedule a genetic counseling appointment.